This study aimed to develop and evaluate a spatiotemporal deep-neural-network (stDNN) using resting-state fMRI (rs-fMRI) data to identify brain biomarkers associated with isolated REM sleep behavior disorder (iRBD) and Parkinson's disease (PD) and to differentiate these conditions from controls. The final sample included 771 subjects, comprising 423 patients with PD, 144 with iRBD, and 204 healthy controls. stDNN model was applied to mean timeseries extracted for each subject from rs-fMRI data. By integrating spatio-temporal features, the network classified subjects based on distinct neural patterns. Model generalizability was assessed using subject-wise k-fold cross-validation. Explainable artificial intelligence (XAI) methods were applied. stDNN achieved balanced accuracy rates of 71.0% in distinguishing controls from PD and up to 71.9% in middle-stage PD cases. It also demonstrated over 80% accuracy in differentiating healthy controls from iRBD. XAI analysis highlighted the involvement of fronto-parietal and temporal regions, including the dorsolateral prefrontal cortex, and anterior temporal gyri, in distinguishing controls from PD. In the comparison with iRBD, key contributing areas included the bilateral superior and medial frontal gyri, dorsolateral prefrontal cortex, parietal and occipital regions (lingual gyri and cuneus). This study demonstrates the potential of stDNN to differentiate between iRBD, PD, and controls using rs-fMRI data.
S. Basaia, S. Pisano, E. Sarasso et al.· npj Parkinson's Disease· 0 citations
GBA1 variants increase neuropsychiatric vulnerability in Parkinson's disease (PD). In a multicenter cohort of 234 PD patients (78 GBA-PD, 156 nonGBA-PD), we investigated how GBA1 genotype and sex relate to depression. REM sleep behavior disorder was associated with depression in GBA-PD, while sex, cognition, and motor complications were predictors in nonGBA-PD. Depressive symptoms were more severe and progressed faster in GBA-PD, supporting specific monitoring of this genetic subgroup.
P. Mitrotti, M. Avenali, C. Artusi et al.· npj Parkinson's Disease· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.